Caspase-mediated cell death contributes to the pathogenesis of motor neuron degeneration in the mutant SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS), along with other factors such as inflammation and oxidative damage. By screening a drug library, we found that melatonin, a pineal hormone, inhibited cytochrome c release in purified mitochondria and prevented cell death in cultured neurons. In this study, we evaluated whether melatonin would slow disease progression in SOD1 G93A mice. We demonstrate that melatonin significantly delayed disease onset, neurological deterioration and mortality in ALS mice. ALS-associated ventral horn atrophy and motor neuron death were also inhibited by melatonin treatment. Melatonin inhibited Rip2/caspase-1 pathway activation, blocked the release of mitochondrial cytochrome c, and reduced the overexpression and activation of caspase-3. Moreover, for the first time, we determined that disease progression was associated with the loss of both melatonin and the melatonin receptor 1A (MT1) in the spinal cord of ALS mice. These results demonstrate that melatonin is neuroprotective in transgenic ALS mice, and this protective effect is mediated through its effects on the caspase-mediated cell death pathway. Furthermore, our data suggest that melatonin and MT1 receptor loss may play a role in the pathological phenotype observed in ALS. The above observations indicate that melatonin and modulation of Rip2/ caspase-1/cytochrome c or MT1 pathways may be promising therapeutic approaches for ALS.
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a progressive and selective loss of motor neurons, resulting in progressive paralysis and death (Rowland and Shneider, 2001) . Although the exact pathophysiological mechanisms are not fully understood, the activation of caspase-mediated cell death pathways plays an important role in neuronal death in ALS patients and animal models (Friedlander, 2003; Li et al., 2000) . The potential importance of apoptotic pathways in ALS is suggested by several observations: altered Bcl-2-family proteins result in a predisposition towards cell death; increased expression or activation of caspase-1 and caspase-3 in ALS; and appearance of morphological features in dying motor neurons that are reminiscent of apoptosis (Pasinelli et al., 2000; Sathasivam et al., 2001; Vukosavic et al., 1999) . Further supporting evidence is the occurrence of apoptosis-related mitochondrial dysfunction in the spinal cord associated with disease progression (Dupuis et al., 2004; Shi et al., 2010) . Consistent with the
